S

Sichuan Goldstone Asia Pharmaceutical Inc
SZSE:300434

Watchlist Manager
Sichuan Goldstone Asia Pharmaceutical Inc
SZSE:300434
Watchlist
Price: 10.87 CNY -0.09% Market Closed
Market Cap: 4.4B CNY

Intrinsic Value

The intrinsic value of one Sichuan Goldstone Asia Pharmaceutical Inc stock under the Base Case scenario is 7.63 CNY. Compared to the current market price of 10.87 CNY, Sichuan Goldstone Asia Pharmaceutical Inc is Overvalued by 30%.

Intrinsic Value
7.63 CNY
Overvaluation 30%
Intrinsic Value
Price
S
Worst Case
Base Case
Best Case

Valuation History
Sichuan Goldstone Asia Pharmaceutical Inc

What is Valuation History?
Ask AI Assistant
What other research platforms think about Sichuan Goldstone Asia Pharmaceutical Inc?

Let our AI compare Alpha Spread’s intrinsic value with external valuations from Simply Wall St, GuruFocus, ValueInvesting.io, Seeking Alpha, and others.

Discover External Valuations
Why is Sichuan Goldstone Asia Pharmaceutical Inc valued this way?

Let our AI break down the key assumptions behind the intrinsic value calculation for Sichuan Goldstone Asia Pharmaceutical Inc.

Explain Valuation
Compare Sichuan Goldstone Asia Pharmaceutical Inc to
Custom
Choose any stock to compare

Fundamental Analysis

Profitability Score
Profitability Due Diligence

Loading...
Loading...
Loading...
Loading...
Profitability
Score

Solvency Score
Solvency Due Diligence

Loading...
Loading...
Loading...
Loading...
Solvency
Score
Sichuan Goldstone Asia Pharmaceutical Inc
Company Overview
Loading...
Economic Moat
Loading...
Management
Loading...
Contacts
Loading...
How do you feel about Sichuan Goldstone Asia Pharmaceutical Inc?
Bearish
Neutral
Bullish
Efficiency

Free Cash Flow Analysis
Sichuan Goldstone Asia Pharmaceutical Inc

Last Value
3-Years Average
FCF Margin
Conversion Rate

Earnings Waterfall
Sichuan Goldstone Asia Pharmaceutical Inc

Wall St
Price Targets

Price Targets Summary
Sichuan Goldstone Asia Pharmaceutical Inc

There are no price targets for Sichuan Goldstone Asia Pharmaceutical Inc.
Lowest
Price Target
Not Available
Average
Price Target
Not Available
Highest
Price Target
Not Available
View Analyst Estimates
View Analyst Estimates

Dividends

Dividend Yield
Lowest
Average
Highest
Dividend Per Share
N/A
Growth 3Y
Growth 5Y
Growth 10Y
Dividend Safety Score
Very
Unsafe
Unsafe
Safe
Very
Safe
0
25
50
75
100
Shareholder Yield

Current shareholder yield for Sichuan Goldstone Asia Pharmaceutical Inc is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
Lowest
Average
Highest
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

Competitive Landscape

Company Market Cap Intrinsic Valuation Profitability Solvency Price Change
1Y 3Y 5Y
What is the Intrinsic Value of one Sichuan Goldstone Asia Pharmaceutical Inc stock?

The intrinsic value of one Sichuan Goldstone Asia Pharmaceutical Inc stock under the Base Case scenario is 7.63 CNY.

Is Sichuan Goldstone Asia Pharmaceutical Inc stock undervalued or overvalued?

Compared to the current market price of 10.87 CNY, Sichuan Goldstone Asia Pharmaceutical Inc is Overvalued by 30%.

Back to Top